S&P 500 6,976.44 ▲ 37.41 (+0.54%)
DOW 49,407.66 ▲ 515.19 (+1.05%)
NASDAQ 23,592.11 ▲ 130.29 (+0.56%)
US Markets Closed

BUGDF

Bumrungrad Hospital Public Company Limited

Price Chart
Latest Quote

$5.40

Current Price
Previous Close $4.75
Open $5.40
Day High $5.40
Day Low $5.40
Volume 2,000
Fetched: 2026-02-02T22:46:49
Stock Information
Note: Financial values converted from THB to USD
Quarterly Dividend / Yield $0.15 / 3.19%
Shares Outstanding 794.96M
Total Debt $3.52M
Cash Equivalents $398.25M
Revenue $805.64M
Net Income $238.72M
Sector Healthcare
Industry Medical Care Facilities
Market Cap $5.53B
P/E Ratio 19.29
EPS (TTM) $0.28
Exchange PNK
🌐 Visit Website
📊 Custom Metrics & Score
Score: 35/42
Debt to Equity 0.01
Debt to Earnings 0.01
Current Ratio 4.37
Quick Ratio 4.21
Avg Revenue Growth 26.60%
Profit Margin 30.23%
Return on Equity 28.28%
Avg FCF Growth 46.03%
FCF Yield 133.01%
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
Date Close Volume
2026-01-30 $4.75 0
2026-01-29 $4.75 0
2026-01-28 $4.75 0
2026-01-27 $4.75 0
2026-01-26 $4.75 0
2026-01-23 $4.75 0
2026-01-22 $4.75 0
2026-01-21 $4.75 0
2026-01-20 $4.75 0
2026-01-16 $4.75 0
2026-01-15 $4.75 0
2026-01-14 $4.75 1,300
2026-01-13 $5.40 0
2026-01-12 $5.40 0
2026-01-09 $5.40 0
2026-01-08 $5.40 0
2026-01-07 $5.40 0
2026-01-06 $5.40 0
2026-01-05 $5.40 0
About Bumrungrad Hospital Public Company Limited

Bumrungrad Hospital Public Company Limited owns and operates hospitals in Thailand and internationally. It offers services in the areas of allergy, arrhythmia, behavioural health, breast, home, heart valve, robotic surgery, rehabilitation, spine, paediatrics, colorectal surgery, complex coronary artery intervention, comprehensive sleep, cornea transplant, dental, diagnostic, dialysis, radiology and nuclear medicine, digestive disease, ear, nose, throat, emergency, endocrinology, esperance, diabetes, expatriate liaison, eye, fertility, gastrointestinal motility, health screening, holistic wound care, horizon regional cancer, hyperbaric oxygen therapy, nephrology, neuroscience, orthopaedics, perinatal, plastic surgery, pulmonary, refractive surgery, memory, robotic scoliosis, skin, sports medicine and joint, surgery, travel medicine, urology, scientific wellness, skin and aesthetic, and women's centers. The company also operates breastfeeding, Yangon, COVID-19 recovery, IVF, hearing and balance, medical, new life healthy aging, Parkinson's disease and movement disorders, pride, surgery, and vaccine clinics and centers. In addition, it operates spine institute, heart institute, and intensive care unit; and offers nutrition services, pharmacy services, preventive genomics and integrative medicine services. Further, the company offers clinical research, hospital consulting and management, healthcare personnel development and training, healthcare referral, and digital platform services. Additionally, it is involved in the distribution of pharmaceutical and medical goods in specialized stores; development of software for healthcare services; holding of real estate assets; and manufacture and sale of vitamin supplements. Bumrungrad Hospital Public Company Limited was founded in 1975 and is based in Bangkok, Thailand.

Income Statement (Annual)
Revenue
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Reconciled Cost Of Revenue $12,503,044,110 $12,894,825,868 $11,099,259,807 $7,730,980,529
Cost Of Revenue $12,503,044,110 $12,894,825,868 $11,099,259,807 $7,730,980,529
Total Revenue $25,717,577,317 $25,376,158,560 $20,720,563,655 $12,460,420,942
Operating Revenue $25,717,577,317 $25,376,158,560 $20,720,563,655 $12,460,420,942
Expenses
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Interest Expense $8,334,812 $2,393,568 $3,546,789 $119,755,897
Total Expenses $16,529,507,397 $16,904,216,536 $14,710,235,002 $10,882,790,822
Rent Expense Supplemental $85,719,000 $71,031,000 $46,112,000 -
Other Income Expense $-23,161,280 $27,158,335 $-3,780,644 $-70,779,025
Net Non Operating Interest Income Expense $271,138,420 $138,554,894 $42,407,483 $-50,971,417
Interest Expense Non Operating $8,334,812 $2,393,568 $3,546,789 $119,755,897
Operating Expense $4,026,463,287 $4,009,390,668 $3,610,975,195 $3,151,810,293
Other Operating Expenses $-144,872,620 $-170,761,457 $-186,969,181 $-144,095,598
Selling And Marketing Expense $728,369,281 $684,879,695 $586,333,726 $358,446,061
General And Administrative Expense $3,442,966,626 $3,495,272,430 $3,211,610,650 $2,937,459,830
Income & Earnings
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Net Income From Continuing Operation Net Minority Interest $7,774,725,876 $7,006,450,979 $4,938,221,850 $1,215,678,226
Net Interest Income $271,138,420 $138,554,894 $42,407,483 $-50,971,417
Interest Income $279,473,232 $140,948,462 $45,954,272 $68,784,480
Normalized Income $7,793,595,427 $6,983,535,488 $4,940,912,789 $1,265,386,767
Net Income From Continuing And Discontinued Operation $7,774,725,876 $7,006,450,979 $4,938,221,850 $1,215,678,226
Total Operating Income As Reported $9,165,335,922 $8,499,997,647 $6,007,057,978 $1,519,269,038
Net Income Common Stockholders $7,774,725,876 $7,006,450,979 $4,938,221,850 $1,215,678,226
Net Income $7,774,725,876 $7,006,450,979 $4,938,221,850 $1,215,678,226
Net Income Including Noncontrolling Interests $7,832,056,977 $7,055,131,651 $4,976,762,173 $1,240,032,772
Net Income Continuous Operations $7,832,056,977 $7,055,131,651 $4,976,762,173 $1,240,032,772
Pretax Income $9,436,047,060 $8,637,655,253 $6,048,955,492 $1,455,879,678
Earnings From Equity Interest $-427,282 $-897,288 $-509,969 $-12,417,943
Interest Income Non Operating $279,473,232 $140,948,462 $45,954,272 $68,784,480
Operating Income $9,188,069,920 $8,471,942,024 $6,010,328,653 $1,577,630,120
Gross Profit $13,214,533,207 $12,481,332,692 $9,621,303,848 $4,729,440,413
Special Income Charges - - $0 $-56,448,127
Per Share Metrics
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Diluted EPS $8.96 $8.08 $5.69 $1.40
Basic EPS $9.78 $8.81 $6.21 $1.53
Other
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Tax Effect Of Unusual Items $-3,864,447 $5,140,132 $-579,736 $-8,652,541
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $10,544,351,870 $9,708,761,198 $7,172,647,956 $2,813,918,292
Total Unusual Items $-22,733,998 $28,055,623 $-3,270,675 $-58,361,082
Total Unusual Items Excluding Goodwill $-22,733,998 $28,055,623 $-3,270,675 $-58,361,082
Reconciled Depreciation $1,077,236,000 $1,096,768,000 $1,116,875,000 $1,179,921,635
EBITDA (Bullshit earnings) $10,521,617,872 $9,736,816,821 $7,169,377,281 $2,755,557,210
EBIT $9,444,381,872 $8,640,048,821 $6,052,502,281 $1,575,635,575
Diluted Average Shares $867,415,000 $867,415,000 $867,415,000 $867,415,000
Basic Average Shares $794,911,000 $794,886,000 $794,838,000 $794,586,000
Diluted NI Availto Com Stockholders $7,774,725,876 $7,006,450,979 $4,938,221,850 $1,215,678,226
Minority Interests $-57,331,101 $-48,680,672 $-38,540,323 $-24,354,546
Tax Provision $1,603,990,083 $1,582,523,602 $1,072,193,319 $215,846,906
Gain On Sale Of Security $-22,733,998 $28,055,623 $-3,270,675 $-1,912,955
Selling General And Administration $4,171,335,907 $4,180,152,125 $3,797,944,376 $3,295,905,891
Other Gand A $3,442,966,626 $3,495,272,430 $3,211,610,650 $2,937,459,830
Gain On Sale Of Business - - $0 $-56,448,127
Fetched: 2026-02-02
Balance Sheet (Annual)
Assets
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Net Tangible Assets $26,839,628,773 $23,130,078,613 $18,996,156,351 $16,495,111,963
Total Assets $32,653,044,667 $29,212,105,247 $24,258,811,521 $20,856,804,710
Total Non Current Assets $15,921,514,726 $13,527,128,018 $12,840,033,590 $12,794,827,524
Other Non Current Assets $78,410,364 $94,315,180 $61,144,293 $72,299,809
Non Current Deferred Assets $311,110,571 $309,232,619 $300,842,074 $331,062,128
Non Current Deferred Taxes Assets $311,110,571 $309,232,619 $300,842,074 $331,062,128
Non Current Note Receivables $0 $0 $0 $0
Investmentin Financial Assets $2,013,551,782 $71,441,000 $231,000 $231,000
Goodwill And Other Intangible Assets $648,051,106 $671,050,035 $709,339,413 $791,004,676
Other Intangible Assets $587,959,000 $610,477,000 $648,586,000 $719,987,000
Current Assets $16,731,529,941 $15,684,977,229 $11,418,777,931 $8,061,977,186
Other Current Assets $151,225,698 $54,685,685 $26,465,819 $225,527,011
Prepaid Assets $128,618,071 $114,087,714 $132,266,308 $112,248,323
Inventory $355,939,366 $362,256,456 $325,739,412 $327,556,468
Receivables $3,982,322,000 $4,408,468,000 $2,658,143,000 $1,461,049,000
Other Receivables $68,297,000 $55,281,000 $18,233,000 $18,291,000
Accounts Receivable $3,827,209,000 $4,265,555,000 $2,639,910,000 $1,442,748,000
Allowance For Doubtful Accounts Receivable $-192,968,000 $-240,892,000 $-218,598,000 $-222,890,000
Gross Accounts Receivable $4,020,177,000 $4,506,447,000 $2,858,508,000 $1,665,638,000
Cash Cash Equivalents And Short Term Investments $12,113,424,806 $10,745,479,374 $8,276,163,392 $5,935,596,384
Cash And Cash Equivalents $3,259,383,269 $3,774,053,872 $2,091,126,392 $1,802,026,384
Cash Equivalents $3,236,584,000 $3,750,484,000 $2,071,775,000 $1,789,220,000
Cash Financial $22,799,000 $23,570,000 $19,351,000 $12,806,000
Financial Assets Designatedas Fair Value Through Profitor Loss Total - $71,210,000 $0 -
Debt
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Debt $139,444,086 $91,144,270 $63,281,521 $94,374,480
Long Term Debt And Capital Lease Obligation $102,355,412 $74,183,775 $39,702,538 $53,885,977
Long Term Debt $24,280,648 $24,220,825 $24,146,359 $23,224,510
Current Debt And Capital Lease Obligation $37,088,674 $16,960,495 $23,578,983 $40,488,503
Liabilities
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Liabilities Net Minority Interest $4,852,113,611 $5,114,316,723 $4,253,493,401 $3,238,867,367
Total Non Current Liabilities Net Minority Interest $1,025,384,485 $929,965,170 $838,525,401 $954,651,913
Non Current Deferred Liabilities $2,898,309 $2,127,958 $1,624,417 $4,766,893
Non Current Deferred Taxes Liabilities $2,898,309 $2,127,958 $1,624,417 $4,766,893
Current Liabilities $3,826,729,126 $4,184,351,553 $3,414,968,000 $2,284,215,454
Other Current Liabilities $215,905,793 $176,367,014 $142,203,169 $265,270,097
Payables And Accrued Expenses $3,573,734,659 $3,991,024,044 $3,249,185,848 $1,978,456,854
Payables $1,674,146,462 $1,881,672,945 $1,701,801,948 $943,073,149
Other Payable $195,867,000 $156,022,000 $214,287,000 $126,125,000
Total Tax Payable $525,392,462 $803,179,945 $616,671,948 $138,033,149
Income Tax Payable $525,392,462 $803,179,945 $616,671,948 $138,033,149
Accounts Payable $952,887,000 $922,471,000 $870,843,000 $678,915,000
Equity
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Common Stock Equity $27,486,829,314 $23,800,248,083 $19,704,614,999 $17,284,935,774
Preferred Stock Equity $850,565 $880,565 $880,765 $1,180,865
Total Equity Gross Minority Interest $27,800,931,056 $24,097,788,524 $20,005,318,120 $17,617,937,343
Stockholders Equity $27,487,679,879 $23,801,128,648 $19,705,495,764 $17,286,116,639
Other Equity Interest $320,000,000 $320,000,000 $320,000,000 $320,000,000
Gains Losses Not Affecting Retained Earnings $-152,243,170 $-160,860,973 $-215,353,273 $-134,205,068
Other Equity Adjustments $99,311,159 $88,005,827 $88,005,827 $88,005,827
Retained Earnings $26,074,302,527 $22,396,369,099 $18,355,228,515 $15,854,701,185
Long Term Equity Investment $130,263,903 $13,191,184 $1,476,810 $1,437,911
Other
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Ordinary Shares Number $794,915,942 $794,885,942 $794,885,742 $794,585,642
Share Issued $794,915,942 $794,885,942 $794,885,742 $794,585,642
Tangible Book Value $26,838,778,208 $23,129,198,048 $18,995,275,586 $16,493,931,098
Invested Capital $27,511,109,962 $23,824,468,908 $19,728,761,358 $17,308,160,284
Working Capital $12,904,800,815 $11,500,625,676 $8,003,809,931 $5,777,761,732
Capital Lease Obligations $115,163,438 $66,923,445 $39,135,162 $71,149,970
Total Capitalization $27,511,960,527 $23,825,349,473 $19,729,642,123 $17,309,341,149
Minority Interest $313,251,177 $296,659,876 $299,822,356 $331,820,704
Foreign Currency Translation Adjustments $-251,554,329 $-248,866,800 $-303,359,100 $-222,210,895
Additional Paid In Capital $449,854,015 $449,854,015 $449,854,015 $449,854,015
Capital Stock $795,766,507 $795,766,507 $795,766,507 $795,766,507
Common Stock $794,915,942 $794,885,942 $794,885,742 $794,585,642
Preferred Stock $850,565 $880,565 $880,765 $1,180,865
Employee Benefits $920,130,764 $853,653,437 $797,198,446 $895,999,043
Long Term Capital Lease Obligation $78,074,764 $49,962,950 $15,556,179 $30,661,467
Current Capital Lease Obligation $37,088,674 $16,960,495 $23,578,983 $40,488,503
Current Accrued Expenses $1,899,588,197 $2,109,351,099 $1,547,383,900 $1,035,383,705
Dueto Related Parties Current $0 $0 $0 $0
Investments And Advances $2,143,815,685 $84,632,184 $1,707,810 $1,668,911
Available For Sale Securities $2,013,551,782 $231,000 $231,000 $231,000
Investmentsin Joint Venturesat Cost $130,085,121 $12,961,545 $0 -
Investmentsin Associatesat Cost $178,782 $229,639 $1,476,810 $1,437,911
Investmentsin Subsidiariesat Cost $0 $0 $0 $0
Goodwill $60,092,106 $60,573,035 $60,753,413 $71,017,676
Net PPE $12,740,127,000 $12,367,898,000 $11,767,000,000 $11,598,792,000
Accumulated Depreciation $-14,026,952,000 $-13,557,448,000 $-13,010,869,000 $-12,348,234,000
Gross PPE $26,767,079,000 $25,925,346,000 $24,777,869,000 $23,947,026,000
Construction In Progress $1,194,505,000 $1,165,473,000 $965,239,000 $1,213,703,000
Other Properties $10,330,312,000 $9,923,049,000 $9,702,610,000 $9,134,218,000
Machinery Furniture Equipment $836,858,000 $757,055,000 $729,935,000 $731,310,000
Buildings And Improvements $8,741,830,000 $8,416,121,000 $8,029,758,000 $7,735,778,000
Land And Improvements $5,663,574,000 $5,663,648,000 $5,350,327,000 $5,132,017,000
Properties $0 $0 $0 $0
Other Inventories $366 $456 $412 $468
Finished Goods $181,710,000 $189,595,000 $167,637,000 $168,667,000
Raw Materials $174,229,000 $172,661,000 $158,102,000 $158,889,000
Duefrom Related Parties Current $86,816,000 $87,632,000 $0 $10,000
Other Short Term Investments $8,854,041,537 $6,971,425,502 $6,185,037,000 $4,133,570,000
Preferred Shares Number - $880,565 $880,765 $1,180,865
Held To Maturity Securities - $71,210,000 $0 -
Fetched: 2026-02-02
Cash Flow Statement (Annual)
Free Cash Flow
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Free Cash Flow $7,350,237,622 $5,419,119,872 $4,992,015,958 $2,586,916,760
Operating Activities
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow $8,671,238,698 $7,094,364,455 $6,212,622,281 $3,556,157,972
Cash Flow From Continuing Operating Activities $8,671,238,635 $7,094,364,024 $6,212,622,583 $3,556,157,972
Operating Gains Losses $132,888,531 $63,190,263 $139,022,247 $182,906,949
Investing Activities
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Capital Expenditure $-1,321,001,076 $-1,675,244,583 $-1,220,606,323 $-969,241,212
Investing Cash Flow $-4,984,873,448 $-2,428,594,057 $-3,222,520,528 $2,252,062,795
Cash Flow From Continuing Investing Activities $-4,984,873,448 $-2,428,594,057 $-3,222,520,528 $2,252,062,795
Financing Activities
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Financing Cash Flow $-4,224,199,088 $-3,050,793,027 $-2,656,112,105 $-5,255,447,294
Cash Flow From Continuing Financing Activities $-4,224,199,088 $-3,050,793,027 $-2,656,112,105 $-5,255,447,294
Net Other Financing Charges $-54,179,217 $-54,349,342 $-40,661,190 $-11,855,942
Cash Dividends Paid $-4,101,253,278 $-2,938,460,036 $-2,542,652,804 $-2,544,865,180
Dividends Received Cfi $0 $0 $0 $0
Other
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Repayment Of Debt $-38,537,205 $-27,783,649 $-42,598,111 $-2,544,276,172
End Cash Position $3,259,383,269 $3,774,053,872 $2,091,126,392 $1,802,026,384
Beginning Cash Position $3,774,053,872 $2,091,126,392 $1,802,026,384 $1,229,423,953
Effect Of Exchange Rate Changes $23,163,235 $67,950,109 $-44,889,640 $19,828,958
Changes In Cash $-537,833,838 $1,614,977,371 $333,989,648 $552,773,473
Interest Paid Cff $-30,229,388 $-30,200,000 $-30,200,000 $-154,450,000
Net Issuance Payments Of Debt $-38,537,205 $-27,783,649 $-42,598,111 $-2,544,276,172
Net Long Term Debt Issuance $-38,537,205 $-27,783,649 $-42,598,111 $-2,544,276,172
Long Term Debt Payments $-38,537,205 $-27,783,649 $-42,598,111 $-2,544,276,172
Interest Received Cfi $209,850,633 $115,111,095 $43,770,485 $82,229,555
Net Investment Purchase And Sale $-3,798,785,576 $-857,598,805 $-2,051,466,315 $3,131,141,630
Sale Of Investment $9,680,431,734 $5,414,338,847 $3,814,583,255 $6,144,744,200
Purchase Of Investment $-13,479,217,310 $-6,271,937,652 $-5,866,049,570 $-3,013,602,570
Net Business Purchase And Sale $-117,500,000 $-16,736,445 $-500,000 $5,562,000
Purchase Of Business $-117,500,000 $-16,736,445 $-500,000 $0
Net Intangibles Purchase And Sale $-104,566,070 $-103,054,305 $-74,638,373 $-166,172,588
Purchase Of Intangibles $-104,566,070 $-103,054,305 $-74,638,373 $-166,172,588
Net PPE Purchase And Sale $-1,173,872,435 $-1,566,315,597 $-1,139,686,325 $-800,697,802
Sale Of PPE $42,562,571 $5,874,681 $6,281,625 $2,370,822
Purchase Of PPE $-1,216,435,006 $-1,572,190,278 $-1,145,967,950 $-803,068,624
Taxes Refund Paid $-1,894,773,201 $-1,411,524,726 $-600,119,899 $-103,671,673
Change In Working Capital $206,008,159 $-1,177,081,567 $-463,358,106 $734,999,291
Change In Other Current Liabilities $39,538,806 $34,163,734 $-123,066,631 $166,990,163
Change In Other Current Assets $-41,069,500 $25,947,381 $216,345,148 $-210,309,582
Change In Payables And Accrued Expense $-178,072,626 $579,188,930 $727,295,822 $130,830,401
Change In Accrued Expense $-217,810,617 $559,799,412 $509,248,934 $-33,018,820
Change In Payable $39,737,991 $19,389,518 $218,046,888 $163,849,221
Change In Prepaid Assets $-14,530,357 $18,178,594 $-20,017,985 $-4,920,228
Change In Inventory $7,227,293 $-34,768,766 $-799,761 $-18,454,266
Change In Receivables $392,914,543 $-1,799,791,440 $-1,263,114,699 $670,862,803
Other Non Cash Items $-307,603,159 $-193,835,084 $-93,805,579 $28,172,279
Unrealized Gain Loss On Investment Securities $-11,809,749 $0 - -
Provisionand Write Offof Assets $33,231,412 $79,986,585 $62,603,122 $77,043,796
Asset Impairment Charge $13,645 $-794,269 $2,450,004 $906,017
Depreciation Amortization Depletion $1,077,236,000 $1,096,768,000 $1,116,875,000 $1,179,921,635
Depreciation And Amortization $1,077,236,000 $1,096,768,000 $1,116,875,000 $1,179,921,635
Amortization Cash Flow $114,005,000 $139,717,000 $151,261,000 -
Amortization Of Intangibles $114,005,000 $139,717,000 $151,261,000 -
Depreciation $963,231,000 $957,051,000 $965,614,000 -
Pension And Employee Benefit Expense $138,232,720 $118,948,839 $126,107,527 $120,860,978
Earnings Losses From Equity Investments $427,282 $897,288 $509,969 $12,417,943
Gain Loss On Sale Of PPE $-5,771,471 $-56,655,864 $12,404,751 $-6,820,099
Net Income From Continuing Operations $9,436,047,060 $8,637,655,253 $6,048,955,492 $1,455,879,678
Sale Of Business - - $0 $5,562,000
Gain Loss On Sale Of Business - - $0 $56,448,127
Fetched: 2026-02-02